These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34274706)

  • 1. A review on pharmaceuticals removal from waters by single and combined biological, membrane filtration and ultrasound systems.
    Alfonso-Muniozguren P; Serna-Galvis EA; Bussemaker M; Torres-Palma RA; Lee J
    Ultrason Sonochem; 2021 Aug; 76():105656. PubMed ID: 34274706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid bioreactor based on insolubilized tyrosinase and laccase catalysis and microfiltration membrane remove pharmaceuticals from wastewater.
    Ba S; Haroune L; Soumano L; Bellenger JP; Jones JP; Cabana H
    Chemosphere; 2018 Jun; 201():749-755. PubMed ID: 29549858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid membrane filtration-advanced oxidation processes for removal of pharmaceutical residue.
    Rosman N; Salleh WNW; Mohamed MA; Jaafar J; Ismail AF; Harun Z
    J Colloid Interface Sci; 2018 Dec; 532():236-260. PubMed ID: 30092507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration.
    Petrovic M; de Alda MJ; Diaz-Cruz S; Postigo C; Radjenovic J; Gros M; Barcelo D
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3979-4003. PubMed ID: 19736231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of Pharmaceutical and Personal Care Products (PPCPs) from Municipal Waste Water with Integrated Membrane Systems, MBR-RO/NF.
    Wang Y; Wang X; Li M; Dong J; Sun C; Chen G
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29401723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
    Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
    Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace analysis of polar pharmaceuticals in wastewater by LC-MS-MS: comparison of membrane bioreactor and activated sludge systems.
    Celiz MD; Pérez S; Barceló D; Aga DS
    J Chromatogr Sci; 2009 Jan; 47(1):19-25. PubMed ID: 19161652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The application of membrane bioreactors as decentralised systems for removal of endocrine disrupting chemicals and pharmaceuticals.
    Le-Minh N; Coleman HM; Khan SJ; van Luer Y; Trang TT; Watkins G; Stuetz RM
    Water Sci Technol; 2010; 61(5):1081-8. PubMed ID: 20220228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removals of pharmaceutical compounds at different sludge particle size fractions in membrane bioreactors operated under different solid retention times.
    Prasertkulsak S; Chiemchaisri C; Chiemchaisri W; Yamamoto K
    J Hazard Mater; 2019 Apr; 368():124-132. PubMed ID: 30669036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR-RO.
    Dolar D; Gros M; Rodriguez-Mozaz S; Moreno J; Comas J; Rodriguez-Roda I; Barceló D
    J Hazard Mater; 2012 Nov; 239-240():64-9. PubMed ID: 22476093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pharmaceutical micropollutants on the membrane fouling of a submerged MBR treating municipal wastewater: case of continuous pollution by carbamazepine.
    Li C; Cabassud C; Reboul B; Guigui C
    Water Res; 2015 Feb; 69():183-194. PubMed ID: 25481077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of pharmaceutical residue in municipal wastewater by DAF (dissolved air flotation)-MBR (membrane bioreactor) and ozone oxidation.
    Choi M; Choi DW; Lee JY; Kim YS; Kim BS; Lee BH
    Water Sci Technol; 2012; 66(12):2546-55. PubMed ID: 23109569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanofiltration as tertiary treatment method for removing trace pharmaceutically active compounds in wastewater from wastewater treatment plants.
    Garcia-Ivars J; Martella L; Massella M; Carbonell-Alcaina C; Alcaina-Miranda MI; Iborra-Clar MI
    Water Res; 2017 Nov; 125():360-373. PubMed ID: 28881212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation into Micropollutant Removal from Wastewaters by a Membrane Bioreactor.
    Kamaz M; Wickramasinghe SR; Eswaranandam S; Zhang W; Jones SM; Watts MJ; Qian X
    Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 30988273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed pharmaceutical wastewater treatment by integrated membrane-aerated biofilm reactor (MABR) system--a pilot-scale study.
    Wei X; Li B; Zhao S; Wang L; Zhang H; Li C; Wang S
    Bioresour Technol; 2012 Oct; 122():189-95. PubMed ID: 22832229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removals of pharmaceutical compounds from hospital wastewater in membrane bioreactor operated under short hydraulic retention time.
    Prasertkulsak S; Chiemchaisri C; Chiemchaisri W; Itonaga T; Yamamoto K
    Chemosphere; 2016 May; 150():624-631. PubMed ID: 26852096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced oxidation and biological integrated processes for pharmaceutical wastewater treatment: A review.
    Adeoye JB; Tan YH; Lau SY; Tan YY; Chiong T; Mubarak NM; Khalid M
    J Environ Manage; 2024 Feb; 353():120170. PubMed ID: 38308991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology.
    Kołecka K; Gajewska M; Stepnowski P; Caban M
    Sci Total Environ; 2019 Jan; 647():149-157. PubMed ID: 30077845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.